(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.data-privacy-src=g;m.parentNode.insertBefore(a,m) })(window,document,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-1666707-3', 'auto'); ga('send', 'pageview');


21st Edition Strategic Project & Portfolio Management for Pharma

17-18 June 2021 Virtual Conference Manage increased granularity and frequency of portfolio optimization and scenario planning and stay ahead of the curve with the right prioritization and execution strategy The

By |2021-04-30T12:50:07+01:00April 30th, 2021|Events & Conferences|0 Comments

12th Annual Biologics Formulation Development & Drug Delivery Forum

Online conference: 14 – 15 June 2021 This event explores how to improve the stability, dosage form, and quality of biopharmaceutical formulations. The increased public attention to biologics development due

By |2021-04-30T09:16:09+01:00April 30th, 2021|Events & Conferences|0 Comments

Update about ANVISA´s role in pharmaceutical patent applications

In August 2017, the Brazilian Health Surveillance Agency (ANVISA) published Resolution No. 168/2017, which establishes the administrative procedures related to ANVISA´s “prior consent” for the granting of pharmaceutical patent applications,

By |2020-04-01T12:48:04+01:00March 12th, 2018|Regulatory Affairs|0 Comments